aspirin has been researched along with bradykinin (1-5) in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, D; Driscoll, E; Faul, J; Hasan, AA; Lucchesi, BR; Normolle, D; Rebello, SS; Schmaier, AH; Smith, E; Srikanth, S; Werns, S | 1 |
| Driscoll, E; Hasa, AA; Lucchesi, BR; Normolle, D; Schmaier, AH; Warnock, M; Werns, SW | 1 |
| Abela, GS; Davis, JM; Hage-Korban, EE; Hasan, AA; Huang, R; Khan, G; Ma, H; Prieto, AR; Schmaier, AH; Schwartz, KA | 1 |
3 other study(ies) available for aspirin and bradykinin (1-5)
| Article | Year |
|---|---|
Thrombostatin inhibits induced canine coronary thrombosis.
Topics: Amino Acid Sequence; Animals; Aspirin; Blood Platelets; Bradykinin; Coronary Thrombosis; Dogs; Humans; In Vitro Techniques; Molecular Sequence Data; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thrombin | 1999 |
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries.
Topics: Animals; Aspirin; Blood Coagulation Tests; Bradykinin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Evaluation; Metabolic Clearance Rate; Peptide Fragments; Platelet Function Tests; Regional Blood Flow; Therapeutic Equivalency; Ticlopidine; Time Factors | 2001 |
Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury.
Topics: Animals; Aspirin; Blood Platelets; Bradykinin; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Catheterization; Cell Size; Disease Models, Animal; Dogs; Lasers; Microscopy, Electron, Scanning; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Scattering, Radiation | 2002 |